NCT02560207View on ClinicalTrials.gov

Randomized Trial of Continuous Versus Intermittent Cefotaxime Infusion on ICU.

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

September 30, 2016

Conditions
Critically Ill
Interventions
DRUG

Cefotaxime

To assess the influence of administration route on target attainment cefotaxime is administered via two IV routes.

Trial Locations (1)

9700 RB

University Medical Center Groningen, Groningen

All Listed Sponsors
lead

University Medical Center Groningen

OTHER

NCT02560207 - Randomized Trial of Continuous Versus Intermittent Cefotaxime Infusion on ICU. | Biotech Hunter | Biotech Hunter